Explore All Access
Check if your research matches the topics covered in Current Neuropharmacology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Current Neuropharmacology : Impact Factor & More
eISSN: 1875-6190pISSN: 1570-159X
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Current Neuropharmacology Key Metrics
CiteScore 
11.7
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Neurology
SNIP
2.3
Topics Covered on Current Neuropharmacology
Oxidative stress
Pyrimidine
Traumatic brain injury
Central nervous system
Alzheimer's disease
Anti-inflammatory
Endocannabinoid system
Neuropathic pain
Benzydamine
Human body
Bipolar disorder
Extracellular matrix
Parkinson's disease
Clinical trial
Attention deficit hyperactivity disorder
Retinal
Multiple sclerosis
Spinal cord
Cannabinoid
Pain management
Current Neuropharmacology Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Neuropharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Neuropharmacology
Appraisal of the Neuroprotective Potentials of Isoeugenol Using <i>In-vitro, In-vivo</i> and <i>In-silico</i> Approaches
- 1 Mar 2025
- Current Neuropharmacology
Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis.
- 1 Feb 2025
- Current neuropharmacology
The Role of Alpha-7 Nicotinic Acetylcholine Receptors in Pain: Potential Therapeutic Implications.
- 1 Feb 2025
- Current Neuropharmacology
Comparison of the Antianhedonic Effects of Repeated-dose Intravenous Ketamine in Older and Younger Adults with Major Depressive Episode.
- 1 Feb 2025
- Current neuropharmacology
Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections?
- 1 Feb 2025
- Current neuropharmacology
Time- and Region-specific Effect of Vortioxetine on Central LPS-induced Transcriptional Regulation of NLRP3 Inflammasome.
- 1 Feb 2025
- Current neuropharmacology
Appraisal of the Neuroprotective Potentials of Isoeugenol Using <i>In-vitro, In-vivo</i> and <i>In-silico</i> Approaches
- 1 Mar 2025
- Current Neuropharmacology
Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis.
- 1 Feb 2025
- Current neuropharmacology
The Role of Alpha-7 Nicotinic Acetylcholine Receptors in Pain: Potential Therapeutic Implications.
- 1 Feb 2025
- Current Neuropharmacology
Comparison of the Antianhedonic Effects of Repeated-dose Intravenous Ketamine in Older and Younger Adults with Major Depressive Episode.
- 1 Feb 2025
- Current neuropharmacology
Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections?
- 1 Feb 2025
- Current neuropharmacology
Time- and Region-specific Effect of Vortioxetine on Central LPS-induced Transcriptional Regulation of NLRP3 Inflammasome.
- 1 Feb 2025
- Current neuropharmacology
Compare Similar Journals with Current Neuropharmacology
Select Journals to Compare with Current Neuropharmacology
Total journals - 8
You can select up to 3 Journals at a time
International Journal of Molecular Sciences
Publisher: MDPI
Scientific Reports
Publisher: NATURE PORTFOLIO
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
Frontiers in Neuroscience
Publisher: FRONTIERS MEDIA SA
Frontiers in Neurology
Publisher: FRONTIERS MEDIA SA
Molecular Neurobiology
Publisher: SPRINGER
Neural Regeneration Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONS
0 Journals Selected to compare with
Current Neuropharmacology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Current Neuropharmacology
How long has Current Neuropharmacology been actively publishing? 
Current Neuropharmacology has been in operation since 2003 till date.
What is the publishing frequency of Current Neuropharmacology?
Current Neuropharmacology published with a Bi-monthly frequency.
How many articles did Current Neuropharmacology publish last year?
In 2023, Current Neuropharmacology publsihed 191 articles.
What is the eISSN & pISSN for Current Neuropharmacology?
For Current Neuropharmacology, eISSN is 1875-6190 and pISSN is 1570-159X.
What is Citescore for Current Neuropharmacology?
Citescore for Current Neuropharmacology is 11.7.
What is SNIP score for Current Neuropharmacology?
SNIP score for Current Neuropharmacology is 2.3.
What is the SJR for Current Neuropharmacology?
SJR for Current Neuropharmacology is Q1.
Who is the publisher of Current Neuropharmacology?
BENTHAM SCIENCE PUBL LTD is the publisher of Current Neuropharmacology.
